196 related articles for article (PubMed ID: 12532086)
1. Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation.
Sampson AP; Pizzichini E; Bisgaard H
J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S49-59; discussion S59-61. PubMed ID: 12532086
[TBL] [Abstract][Full Text] [Related]
2. Introduction: the anti-inflammatory role of cysteinyl leukotriene receptor antagonists in asthma.
Holgate ST; Peters-Golden M
J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S1-4. PubMed ID: 12532082
[No Abstract] [Full Text] [Related]
3. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
4. Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation.
Peters-Golden M; Sampson AP
J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S37-42; discussion S43-8. PubMed ID: 12532085
[TBL] [Abstract][Full Text] [Related]
5. Leukotrienes, antileukotrienes and asthma.
Montuschi P
Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
[TBL] [Abstract][Full Text] [Related]
6. Biological markers in diagnosing, monitoring, and treating asthma: a focus on noninvasive measurements.
Cicutto LC; Downey GP
AACN Clin Issues; 2004; 15(1):97-111. PubMed ID: 14767368
[TBL] [Abstract][Full Text] [Related]
7. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
8. Asthma treatment with inhaled corticosteroids versus antileukotrienes: what exhaled nitric oxide studies do and do not tell us.
Dykewicz MS
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):257-60. PubMed ID: 11686416
[No Abstract] [Full Text] [Related]
9. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
[TBL] [Abstract][Full Text] [Related]
10. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
Leff AR
Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
[TBL] [Abstract][Full Text] [Related]
11. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
12. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
13. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.
Holgate ST; Peters-Golden M; Panettieri RA; Henderson WR
J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S18-34; discussion S34-6. PubMed ID: 12532084
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
Wong WS; Zhu H; Liao W
Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
[TBL] [Abstract][Full Text] [Related]
15. Anti-leukotrienes for asthma.
Calhoun WJ
Curr Opin Pharmacol; 2001 Jun; 1(3):230-4. PubMed ID: 11712744
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model.
Ujino M; Sugimoto N; Koizumi Y; Ro S; Kojima Y; Asae KH; Yamashita N; Ohta K; Nagase H
Allergol Int; 2017 Sep; 66S():S21-S26. PubMed ID: 28647381
[TBL] [Abstract][Full Text] [Related]
17. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.
Sandrini A; Ferreira IM; Gutierrez C; Jardim JR; Zamel N; Chapman KR
Chest; 2003 Oct; 124(4):1334-40. PubMed ID: 14555563
[TBL] [Abstract][Full Text] [Related]
18. Antileukotriene agents in asthma: the dart that kills the elephant?
Renzi PM
CMAJ; 1999 Jan; 160(2):217-23. PubMed ID: 9951445
[TBL] [Abstract][Full Text] [Related]
19. Role of leukotrienes in exercise-induced bronchoconstriction.
Hallstrand TS; Henderson WR
Curr Allergy Asthma Rep; 2009 Jan; 9(1):18-25. PubMed ID: 19063820
[TBL] [Abstract][Full Text] [Related]
20. Antileukotrienes in clinical development for asthma.
Centanni S; Santus P
Expert Opin Investig Drugs; 2002 Jan; 11(1):49-58. PubMed ID: 11772320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
